The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Axonyx Inc.

Axonyx Inc.
Nasdaq: AXYX
Change
symbol:
     
 PROFILE
Axonyx wants to give Alzheimer's the ax. The biotechnology firm licenses and develops potential treatments for degenerative diseases of the central nervous system, including Alzheimer's disease, Creutzfeld-Jakob disease, and dementia. The company has licensed patents for potential therapies from New York University and the National Institute for the Aging. These technologies focus on retarding enzymes and proteins that aggregate to form amyloid plaques in the brain, ultimately causing Alzheimer's. Axonyx has development and licensing agreements for some of its technology with a Serono subsidiary. The firm is also supporting the University of Melbourne's efforts to develop a test to diagnose Alzheimer's.

 COMPETITION
Bayer AG (BAYZY)
Johnson & Johnson (JNJ)
Novartis AG (NVS)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 1.60
1-Yr. Sales Growth: 995.9%
Employees: 8
Revenue per employee: $200,000.00

 KEY PEOPLE
• Marvin S. Hausman
    CEO
• Michael M. Strage
    CFO

 CONTACT INFO
825 Third Ave., 40th Fl.
New York, NY 10022
US
Phone: 212-688-4770
Fax: 212-688-4843
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001